Advances in Clinical and Experimental Medicine

Papers
(The H4-Index of Advances in Clinical and Experimental Medicine is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Cerebral small vessel disease: A review97
Monitoring the kynurenine system: Concentrations, ratios or what else?49
Neurobiological advances of learned fear in humans45
Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review36
Aging, depression and dementia: The inflammatory process31
Recent advances in the study of the comorbidity of depressive and anxiety disorders30
Preclinical modeling in depression and anxiety: Current challenges and future research directions29
Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment24
Advances in EEG-based functional connectivity approaches to the study of the central nervous system in health and disease24
Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?24
Applications for graphene and its derivatives in medical devices: Current knowledge and future applications24
Lethal and life-limiting skeletal dysplasias: Selected prenatal issues21
Arbutin inhibits inflammation and apoptosis by enhancing autophagy via SIRT121
Machine learning in orthodontics: Challenges and perspectives21
Hematological manifestations and complications of COVID-1921
Interleukin 6: biological significance and role in inflammatory bowel diseases19
Baicalein modulates the radiosensitivity of cervical cancer cells in vitro via miR-183 and the JAK2/STAT3 signaling pathway19
Paclitaxel inhibits proliferation and invasion and promotes apoptosis of breast cancer cells by blocking activation of the PI3K/AKT signaling pathway18
CircHIPK3 promotes neuroinflammation through regulation of the miR-124-3p/STAT3/NLRP3 signaling pathway in Parkinson’s disease18
0.05998706817627